Loading...

CRISPR Therapeutics AG Peer Comparison

Metric Value Ranking
Market Cap $3.7 Billion 5/15 NVO
$367.3B
REGN
$71.5B
SRPT
$10.5B
KRYS
$4.4B
CRSP
$3.7B
BEAM
$2.4B
NTLA
$968.6M
VERV
$661.2M
FATE
$142.4M
CRBU
$116.8M
EDIT
$98.2M
RAIN
$26.1M
AVRO
$5.2M
HEPA
$2.1M
CWBR
$1.2M
Gross Margin -100% 14/15 NTLA
100%
FATE
100%
CRBU
100%
REGN
93%
KRYS
90%
NVO
84%
SRPT
80%
VERV
74%
BEAM
62%
CWBR
0%
AVRO
0%
HEPA
0%
RAIN
0%
CRSP
-100%
EDIT
-100%
Profit Margin -100% 9/15 NVO
38%
KRYS
32%
REGN
24%
SRPT
7%
CWBR
0%
AVRO
0%
HEPA
0%
RAIN
0%
CRSP
-100%
EDIT
-100%
NTLA
-100%
FATE
-100%
BEAM
-100%
CRBU
-100%
VERV
-100%
EBITDA margin -18294% 14/15 NVO
52%
KRYS
27%
REGN
26%
SRPT
5%
CWBR
-100%
AVRO
-100%
HEPA
-100%
RAIN
-100%
BEAM
-639%
VERV
-829%
NTLA
-1490%
FATE
-1704%
CRBU
-1889%
CRSP
-18294%
EDIT
-101870%
Quarterly Revenue $602,000 10/15 NVO
$10.5B
REGN
$3.8B
SRPT
$467.2M
KRYS
$83.8M
BEAM
$14.3M
NTLA
$9.1M
VERV
$6.9M
FATE
$3.1M
CRBU
$2.0M
CRSP
$602,000
EDIT
$61,000
CWBR
$0
AVRO
$0
HEPA
$0
RAIN
$0
Quarterly Earnings -$85.9 Million 13/15 NVO
$4.0B
REGN
$917.7M
SRPT
$33.6M
KRYS
$27.2M
RAIN
-$3.0M
CWBR
-$4.3M
HEPA
-$4.9M
AVRO
-$6.8M
CRBU
-$34.7M
FATE
-$47.7M
VERV
-$50.1M
EDIT
-$62.1M
CRSP
-$85.9M
BEAM
-$96.7M
NTLA
-$135.7M
Quarterly Free Cash Flow -$107.1 Million 13/15 NVO
$4.6B
KRYS
$57.8M
CWBR
-$1.8M
HEPA
-$2.5M
AVRO
-$7.6M
FATE
-$29.9M
CRBU
-$33.3M
VERV
-$40.5M
EDIT
-$55.5M
NTLA
-$86.1M
BEAM
-$89.7M
SRPT
-$98.0M
CRSP
-$107.1M
REGN
-$0
RAIN
-$0
Trailing 4 Quarters Revenue $201.6 Million 6/15 NVO
$39.9B
REGN
$14.2B
SRPT
$1.6B
BEAM
$349.6M
KRYS
$241.5M
CRSP
$201.6M
EDIT
$61.8M
NTLA
$43.1M
VERV
$24.4M
FATE
$13.4M
CRBU
$11.5M
CWBR
$0
AVRO
$0
HEPA
$0
RAIN
$0
Trailing 4 Quarters Earnings -$239.6 Million 14/15 NVO
$10.5B
REGN
$3.8B
SRPT
$467.2M
KRYS
$83.8M
BEAM
$14.3M
NTLA
$9.1M
VERV
$6.9M
FATE
$3.1M
CRBU
$2.0M
CRSP
$602,000
EDIT
$61,000
CWBR
-$0
AVRO
-$0
HEPA
-$0
RAIN
-$0
Quarterly Earnings Growth 23% 6/15 SRPT
182%
KRYS
182%
RAIN
84%
AVRO
72%
HEPA
54%
CRSP
23%
NVO
21%
BEAM
-1%
FATE
-6%
VERV
-10%
NTLA
-11%
REGN
-21%
EDIT
-38%
CWBR
-59%
CRBU
-247%
Annual Earnings Growth 31% 6/15 SRPT
208%
KRYS
133%
RAIN
63%
BEAM
58%
HEPA
57%
CRSP
31%
NVO
17%
FATE
8%
REGN
5%
VERV
5%
CWBR
1%
NTLA
-6%
EDIT
-27%
CRBU
-50%
AVRO
-59%
Quarterly Revenue Growth 0% 6/15 VERV
120%
FATE
58%
SRPT
41%
NVO
21%
REGN
10%
CRSP
0%
EDIT
0%
KRYS
0%
CWBR
0%
AVRO
0%
HEPA
0%
RAIN
0%
BEAM
-17%
NTLA
-24%
CRBU
-91%
Annual Revenue Growth -4% 13/15 EDIT
613%
BEAM
351%
FATE
184%
VERV
160%
SRPT
47%
NVO
22%
REGN
5%
KRYS
0%
CWBR
0%
AVRO
0%
HEPA
0%
RAIN
0%
CRSP
-4%
NTLA
-18%
CRBU
-67%
Cash On Hand $225.7 Million 4/15 NVO
$8.4B
KRYS
$374.0M
BEAM
$230.2M
CRSP
$225.7M
SRPT
$197.9M
VERV
$158.7M
NTLA
$120.5M
EDIT
$95.8M
AVRO
$90.8M
FATE
$37.9M
CRBU
$32.0M
CWBR
$6.2M
HEPA
$1.5M
RAIN
$239,857
REGN
-$0
Short Term Debt $16.9 Million 4/15 NVO
$814.2M
SRPT
$91.6M
NTLA
$19.2M
CRSP
$16.9M
EDIT
$16.4M
BEAM
$12.9M
VERV
$10.4M
FATE
$6.9M
HEPA
$2.2M
KRYS
$1.3M
CRBU
$1.2M
RAIN
$806,929
AVRO
$224,000
REGN
-$0
CWBR
-$0
Long Term Debt $210.7 Million 5/15 NVO
$7.6B
REGN
$2.0B
SRPT
$1.3B
BEAM
$298.3M
CRSP
$210.7M
FATE
$92.1M
NTLA
$82.4M
VERV
$60.9M
CRBU
$25.5M
EDIT
$22.1M
KRYS
$0
CWBR
$0
AVRO
$0
HEPA
$0
RAIN
$0
PE -1.00 6/15 SRPT
86.01
KRYS
83.10
NVO
26.29
REGN
16.21
AVRO
0.17
CRSP
-1.00
EDIT
-1.00
NTLA
-1.00
FATE
-1.00
CWBR
-1.00
HEPA
-1.00
BEAM
-1.00
RAIN
-1.00
CRBU
-1.00
VERV
-1.00
PS 18.33 4/15 NVO
62.40
VERV
27.10
NTLA
22.48
CRSP
18.33
KRYS
18.02
FATE
10.59
CRBU
10.18
BEAM
6.77
SRPT
6.39
REGN
5.04
EDIT
1.59
CWBR
-1.00
AVRO
-1.00
HEPA
-1.00
RAIN
-1.00
PB 1.91 6/15 NVO
20.66
SRPT
8.58
KRYS
4.91
BEAM
2.99
REGN
2.05
CRSP
1.91
VERV
1.30
NTLA
1.01
EDIT
0.56
CRBU
0.42
FATE
0.39
CWBR
0.13
AVRO
0.06
HEPA
0.00
RAIN
0.00
PC 16.38 4/15 RAIN
108.73
SRPT
52.97
NVO
43.68
CRSP
16.38
KRYS
11.64
BEAM
10.28
NTLA
8.04
VERV
4.17
FATE
3.76
CRBU
3.65
HEPA
1.42
EDIT
1.03
CWBR
0.19
AVRO
0.06
REGN
-1.00
Liabilities to Equity 0.16 10/15 NVO
2.30
SRPT
1.95
EDIT
0.87
BEAM
0.48
FATE
0.37
CWBR
0.32
VERV
0.31
NTLA
0.22
CRBU
0.22
CRSP
0.16
KRYS
0.11
REGN
0.08
AVRO
0.04
HEPA
0.00
RAIN
0.00
ROA -0.11 6/15 AVRO
33%
REGN
12%
KRYS
5%
NVO
4%
SRPT
3%
CRSP
-11%
BEAM
-12%
VERV
-30%
FATE
-38%
CRBU
-43%
NTLA
-45%
EDIT
-64%
CWBR
-99%
HEPA
-611%
RAIN
-4232%
ROE -0.12 8/15 HEPA
5583%
RAIN
3979%
AVRO
34%
REGN
13%
NVO
12%
SRPT
10%
KRYS
6%
CRSP
-12%
BEAM
-18%
VERV
-39%
FATE
-52%
CRBU
-53%
NTLA
-54%
EDIT
-120%
CWBR
-131%
Current Ratio 7.13 4/15 AVRO
26.32
REGN
13.50
KRYS
10.18
CRSP
7.13
NTLA
5.57
CRBU
5.45
VERV
4.27
CWBR
4.17
FATE
3.73
BEAM
3.08
EDIT
2.16
SRPT
1.51
NVO
1.44
HEPA
0.90
RAIN
0.48
Quick Ratio 6.12 3/15 SRPT
86.01
KRYS
83.10
NVO
26.29
REGN
16.21
AVRO
0.17
CRSP
-1.00
EDIT
-1.00
NTLA
-1.00
FATE
-1.00
CWBR
-1.00
HEPA
-1.00
BEAM
-1.00
RAIN
-1.00
CRBU
-1.00
VERV
-1.00
Long Term Debt to Equity 0.11 7/15 SRPT}
1.07
NVO}
0.43
BEAM}
0.38
FATE}
0.25
EDIT}
0.13
VERV}
0.12
CRSP}
0.11
NTLA}
0.09
CRBU}
0.09
REGN}
0.06
KRYS}
0.00
CWBR}
0.00
AVRO}
0.00
HEPA}
0.00
RAIN}
0.00
Debt to Equity 0.12 7/15 SRPT
1.14
NVO
0.47
FATE
0.27
EDIT
0.22
BEAM
0.20
VERV
0.14
CRSP
0.12
NTLA
0.11
CRBU
0.09
REGN
0.06
KRYS
0.00
CWBR
0.00
AVRO
0.00
RAIN
-1.00
HEPA
-5.47
Burn Rate 2.29 4/15 AVRO
13.22
SRPT
4.76
VERV
2.88
CRSP
2.29
BEAM
2.06
EDIT
1.43
CWBR
1.43
CRBU
0.89
NTLA
0.84
FATE
0.71
HEPA
0.28
RAIN
0.07
REGN
0.00
KRYS
-13.92
NVO
-96.87
Cash to Cap 0.06 11/15 AVRO
17.33
CWBR
5.20
EDIT
0.98
HEPA
0.70
FATE
0.27
CRBU
0.27
VERV
0.24
NTLA
0.12
BEAM
0.10
KRYS
0.09
CRSP
0.06
NVO
0.02
SRPT
0.02
RAIN
0.01
REGN
0.00
CCR 1.25 2/15 KRYS
2.13
CRSP
1.25
NVO
1.15
AVRO
1.11
CRBU
0.96
BEAM
0.93
EDIT
0.89
VERV
0.81
NTLA
0.63
FATE
0.63
HEPA
0.52
CWBR
0.42
SRPT
-2.91
REGN
RAIN
EV to EBITDA -33.58 15/15 SRPT}
526.23
KRYS}
177.39
REGN}
74.25
NVO}
1.45
EDIT}
-0.66
CWBR}
-1.00
AVRO}
-1.00
HEPA}
-1.00
RAIN}
-1.00
CRBU}
-2.92
FATE}
-3.88
NTLA}
-7.00
VERV}
-10.08
BEAM}
-25.20
CRSP}
-33.58
EV to Revenue 18.34 3/15 VERV
23.52
NTLA
22.04
CRSP
18.34
KRYS
16.48
FATE
15.13
CRBU
9.72
SRPT
7.12
BEAM
6.57
REGN
5.18
NVO
1.36
EDIT
0.66
CWBR
-1.00
AVRO
-1.00
HEPA
-1.00
RAIN
-1.00